Duration that elective surgery should be delayed after bare metal stent placement
30 days
p.33
First line pharmacologic class for treating lower urinary tract symptoms (LUTS)
Alpha-blockers
p.51
41 yo woman is evaluated for an expanding slightly pruritic rash with scaling as shown below

Tinea Corporis
Preoperative screening for OSA should occur for this group of patients
All patients undergoing surgery
p.35
71 yo male reports progressive vision loss over several years.

Age-related macular degeneration
Management of suspicious breast mass with negative imaging findings
Biopsy
In patients older than 40 years old, this lab should be obtained prior to initiating testosterone therapy
PSA
p.50
37 yo F evaluated for acne that developed as an adult. She also has episodes of skin flushing in response to eating spicy food. Facial findings shown here:

Rosacea
Characterized by persistent central facial redness that primarily involves the convex surfaces and spares the periocular skin. Telangiectasias, pink papules, pustules, nodules, or ocular disease may also be present, but comedones are not seen. Flushing that lasts longer than 10 minutes in response to a variety of triggers, such as heat, cold, exercise, embarrassment, red wine, or spicy foods, provides supportive historical evidence.
At least 5 days prior to surgery
This pharmacologic class is only effective in treating patients with LUTS secondary to an enlarged prostate.
5a-reductase inhibitors
Function by preventing the conversion of testosterone to dihydroxytestosterone, inhibiting prostate growth; must be taken for at least 6 mo before symptomatic improvement.
p.52
Minimum duration of pharmacologic VTE prophylaxis in patients undergoing orthopedic surgery
10 to 14 days
*Up to 35 days of extended-duration postop ppx is preferred in patients without increased bleeding risk
p.39
Empiric treatment for epididymitis in patients < 35 yo
Rocephin + doxycycline
Type of procedure warrants pre-operative spirometry
Lung Resection
p.35